Real-World Assessment of VEVYE® for Short-Term Symptom and Sign Improvement of Dry Eye Disease in a Neuro-Ophthalmology Clinic: A 6-Month Prospective Observational Study
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
patients from a Neuro Ophthalmology who have dry eye, some of which have neurotrophic keratitis are being analyzed after treatment with Vevye
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age18 yr or older Diagnosis of neuro-ophthalmic condition Clinical diagnosis of dry eye disease OSDI score of 23 or greater at baseline Objective sign present Indicated for VEVYE prior to enrollment Ability and willingness to complete study visits and questionnaires
Locations
United States
Texas
Neuro Ophthalmology of TX
RECRUITING
Houston
Contact Information
Primary
Laura Perez
lperez@neuroeye.com
12817238593
Backup
Rosa A Tang, MD
lperez@neuroeye.com
713-258-0009
Time Frame
Start Date: 2026-03-31
Estimated Completion Date: 2026-11-30
Participants
Target number of participants: 50
Treatments
Dry Eye without neurotrophic changes
Dry Eye with neurotrophic changes
Related Therapeutic Areas
Sponsors
Leads: Neuro-Ophthalmology of Texas
Collaborators: Harrow Inc